Established
Semaglutide
GLP-1 receptor agonist. Ozempic, Wegovy, Rybelsus
Incretín lyf
Rannsóknargögn fyrir hvert lyf, með gögn um stöðvun sem markaðssetningin hefur tilhneigingu til að sleppa.
Established
Tirzepatide
Dual GIP / GLP-1 receptor agonist. Mounjaro, Zepbound
Established
Liraglutide
GLP-1 receptor agonist. Victoza, Saxenda
Established
Dulaglutide
GLP-1 receptor agonist. Trulicity
Promising
Oral semaglutide
GLP-1 receptor agonist, oral. Rybelsus
Popular but weak
Compounded GLP-1 preparations
Unapproved compounded preparation. Various, unbranded
Tengd lesefni
Fasting Evidence
Intermittent fasting, time-restricted eating and meal timing, judged on the trial data.
Metabolism Review
Energy expenditure, insulin resistance and metabolic adaptation, without the folklore.
Weight Loss Evidence
Diets, drugs, behaviour and maintenance — ranked by the strength of the evidence behind them.
Sleep Evidence
Sleep, circadian rhythm and the wearables that claim to measure both.
Þessi síða var þýdd sjálfkrafa úr ensku. Tilvísanir og tölur eru óbreyttar. Lestu upprunalega ensku ef eitthvað hljómar undarlega. Lestu upprunalega ensku